GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medical Developments International MVP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.42

+3.75%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Medical Developments International — daily ASX:MVP

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Medical Developments International on TradingView ↗
Market value
A$46.5m
Last close × shares
Volume
150.9k
Shares, 9 Nov 2026
Price to earnings
71.7

About Medical Developments International

Its shares trade on ASX under the ticker MVP.AX. It has been listed since 15 December 2003. In the fiscal year to 30 June 2026, it reported revenue of A$42.6m and net income of A$626,000. At that date it held total assets of A$68.6m and shareholders' equity of A$55.8m.

Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2003-12-15. The firm is engaged in the manufacture and distribution of a pharmaceutical drug, and medical and veterinary equipment. The firm operates through three segments: Pharmaceuticals, Medical Devices and Veterinary products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia and the United Kingdom, and some sales in New Zealand, Eastern Europe, the Middle East and South America. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia and New Zealand, and some sales in Asia, Europe, the Middle East and North America. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe and the United States. The firm offers a range of products in the areas of pain management, and asthma and resuscitation.

Figures and description from our data supplier, not checked against the company's own report.

More about Medical Developments International →

Latest on Medical Developments International

Our reporting

We have not reported on Medical Developments International yet.

Next results

25 Feb 2027

Due on 25 Feb 2027. Analysts expect earnings of 0.01 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Medical Developments International's ticker?

Medical Developments International trades as MVP.AX on ASX, under ISIN AU000000MVP2.

What was Medical Developments International's last closing price?

0.42 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Medical Developments International next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.